Microprotein-based resistance to fusarium trichothecenes for crop protection

Technology
Conceptual
University

Discovery platform leveraging novel microproteins that confer resistance to trichothecene mycotoxins produced by Fusarium graminearum. A yeast-derived microprotein provides full resistance to lethal doses, with plans to identify plant analogs that could enable durable fungal resistance in crops.

Overview

Fusarium graminearum is a devastating fungal pathogen that produces trichothecenes, potent mycotoxins that contaminate grain crops and threaten food security. This research explores a novel defense mechanism based on microproteins—small proteins encoded by short open reading frames that are often overlooked in traditional genomic analyses. The team has identified a microprotein from yeast that confers full resistance to more than double the lethal dose of the type B trichothecene trichothecin, without altering cell membrane permeability. The central hypothesis is that plants produce analogous microproteins that participate in the fungal-plant interaction, opening a new avenue for engineering durable resistance to Fusarium and reducing mycotoxin contamination in cereals.

Technical specifications
  • Discovery platform: High-throughput screen of a yeast ORF overexpression library to identify genes that confer trichothecene resistance when overexpressed.
  • Lead asset: A novel microprotein providing full resistance at 2.5X the lethal dose of trichothecin, confirmed not to act through generic changes in membrane permeability.
  • Specificity testing: Validated against translation-associated antibiotics to distinguish true resistance mechanisms from non-specific effects.
  • Ligand fishing workflow: His-tagged microprotein immobilized on an NTA sensor chip using Biacore surface plasmon resonance to capture interacting partners from yeast total protein extract.
  • Partner identification: Bound proteins characterized by mass spectrometry, followed by functional bioassays to define interaction partners and mechanism of action.
  • Translational goal: Extend the discovery pipeline to plant-derived microproteins involved in fungus-plant interactions for potential deployment in crop protection.
Technology readiness level

The technology is at an early discovery stage (TRL 2–3). A lead microprotein has been validated in yeast with demonstrated resistance to trichothecin, and specificity controls have been performed. The next phase involves Biacore-based ligand fishing, mass spectrometry identification of binding partners, and functional characterization of microprotein-protein interactions. Extension of the platform to identify plant microproteins with roles in fungal resistance represents the longer-term translational pathway toward agricultural applications.


About Rutgers University

Rutgers University is a comprehensive public research university and New Jersey’s flagship, spanning campuses in New Brunswick–Piscataway, Newark, and Camden. For industry, it offers an integrated clinical and biomedical enterprise through its health system, a statewide extension network for field deployment, and campus-based incubators and pilot-scale facilities that enable prototyping and scale-up. Companies engage through sponsored research, shared core facilities, professional education, and flexible partnership models supported by corporate engagement teams. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and USDA. A dedicated technology transfer office manages IP, licensing, material transfer, and startup formation, providing clear pathways from lab discovery to market.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.